CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-01 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale 10b5-1 | −289 | $23.48 | $7K | 44,931 |
| 2024-09-30 | Cavanagh Bethany J SVP, Finance and Treasurer | Grant or award 10b5-1 | +2,500 | 45,220 | ||
| 2024-09-30 | Evans John M. CEO | Sale 10b5-1 | −60,000 | $24.60 | $1.5M | 938,659 |
| 2024-08-31 | Cavanagh Bethany J SVP, Finance and Treasurer | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-07-02 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −748 | $22.95 | $17K | 68,805 |
| 2024-07-01 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −502 | $23.76 | $12K | 69,553 |
| 2024-06-27 | Evans John M. CEO | Sale 10b5-1 | −60,000 | $24.50 | $1.5M | 998,343 |
| 2024-06-05 | Shaw Christi Director | Grant or award · Stock Option (Right to Buy) | +23,114 | 23,114 | ||
| 2024-06-05 | MARAGANORE JOHN Director | Grant or award · Stock Option (Right to Buy) | +23,114 | 23,114 | ||
| 2024-06-05 | Ho Carole Director | Grant or award · Stock Option (Right to Buy) | +23,114 | 23,114 | ||
| 2024-06-05 | COOPER GRAHAM K Director | Grant or award · Stock Option (Right to Buy) | +23,114 | 23,114 | ||
| 2024-06-05 | Walsh Kathleen E Director | Grant or award · Stock Option (Right to Buy) | +23,114 | 23,114 | ||
| 2024-06-05 | Fishman Mark Director | Grant or award · Stock Option (Right to Buy) | +23,114 | 23,114 | ||
| 2024-04-26 | Burrell Terry-Ann Chief Financial Officer | Grant or award | +12,500 | 82,637 | ||
| 2024-04-26 | Burrell Terry-Ann Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-04-03 | Evans John M. CEO | Grant or award · Stock Option (Right to Buy) 10b5-1 | +99,336 | 99,336 | ||
| 2024-04-03 | Evans John M. CEO | Grant or award · Stock Option (Right to Buy) 10b5-1 | +53,965 | 53,965 | ||
| 2024-04-03 | Ciaramella Giuseppe President | Grant or award · Stock Option (Right to Buy) 10b5-1 | +27,318 | 27,318 | ||
| 2024-04-03 | Ciaramella Giuseppe President | Grant or award · Stock Option (Right to Buy) 10b5-1 | +12,979 | 12,979 | ||
| 2024-04-02 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −16,530 | $30.54 | $505K | 70,060 |
Page 8 of 32 · 630 trades